RUNX2 and thyroid gland carcinoma: Similarly, a study by Niu et al. demonstrated that elevated RUNX2 levels in thyroid carcinoma induce the expression of vasculogenic factors VEGFA and VEGFC, thus promoting tumor invasiveness [148].